Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Mondaza-Hernandez JL"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Reduction of Tumor Growth with RNA-Targeting Treatment of the NAB2-STAT6 Fusion Transcript in Solitary Fibrous Tumor Models.
Autorzy:
Li Y; Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA.; Center for Systems Biology, University of Texas at Dallas, Richardson, TX 75080, USA.
Nguyen JT; Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA.; Center for Systems Biology, University of Texas at Dallas, Richardson, TX 75080, USA.
Ammanamanchi M; Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA.
Zhou Z; Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA.; Center for Systems Biology, University of Texas at Dallas, Richardson, TX 75080, USA.
Harbut EF; Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, TX 75080, USA.
Mondaza-Hernandez JL; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid (IIS/FJD-UAM), 28049 Madrid, Spain.; University Hospital General de Villalba, 28400 Madrid, Spain.
Meyer CA; Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA.
Moura DS; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid (IIS/FJD-UAM), 28049 Madrid, Spain.
Martin-Broto J; Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid (IIS/FJD-UAM), 28049 Madrid, Spain.; University Hospital General de Villalba, 28400 Madrid, Spain.; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, 28040 Madrid, Spain.
Hayenga HN; Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA.
Bleris L; Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA.; Center for Systems Biology, University of Texas at Dallas, Richardson, TX 75080, USA.; Department of Biological Sciences, University of Texas at Dallas, Richardson, TX 75080, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Jun 09; Vol. 15 (12). Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report.
Autorzy:
Moura DS; Institute of Biomedicine of Seville (IBiS, CSIC, HUVR, US), 41013 Seville, Spain.
Díaz-Martín J; Institute of Biomedicine of Seville (IBiS, CSIC, HUVR, US), 41013 Seville, Spain.; Pathology Department, Hospital Virgen del Rocío, 41013 Sevilla, Spain.; Centro de Investigación Biomédica en Red del Cáncer (CIBERONC), 28029 Madrid, Spain.
Bagué S; Pathology Department-CIBERONC, Sant Pau Hospital, 08041 Barcelona, Spain.
Orellana-Fernandez R; Pathology Department-CIBERONC, Sant Pau Hospital, 08041 Barcelona, Spain.
Sebio A; Medical Oncology Department, Sant Pau Hospital, 08041 Barcelona, Spain.
Mondaza-Hernandez JL; Fundacion Jimenez Diaz University Hospital Health Research Institute (IIS/FJD), 28015 Madrid, Spain.
Salguero-Aranda C; Institute of Biomedicine of Seville (IBiS, CSIC, HUVR, US), 41013 Seville, Spain.; Pathology Department, Hospital Virgen del Rocío, 41013 Sevilla, Spain.; Centro de Investigación Biomédica en Red del Cáncer (CIBERONC), 28029 Madrid, Spain.
Rojo F; Pathology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
Hindi N; Fundacion Jimenez Diaz University Hospital Health Research Institute (IIS/FJD), 28015 Madrid, Spain.; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.; General de Villalba University Hospital, 28400 Madrid, Spain.
Fletcher CDM; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA.; Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Martin-Broto J; Fundacion Jimenez Diaz University Hospital Health Research Institute (IIS/FJD), 28015 Madrid, Spain.; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.; General de Villalba University Hospital, 28400 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 13; Vol. 22 (14). Date of Electronic Publication: 2021 Jul 13.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Gene Fusion*
NFI Transcription Factors/*genetics
Oncogene Proteins, Fusion/*genetics
STAT6 Transcription Factor/*genetics
Solitary Fibrous Tumors/*genetics
Solitary Fibrous Tumors/*pathology
Aged ; Female ; Humans ; Prognosis
Czasopismo naukowe
Tytuł:
A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.
Autorzy:
Martin-Broto J; Fundacion Jimenez Díaz University Hospital, 28040 Madrid, Spain.; General de Villalba University Hospital, Collado Villalba, 28400 Madrid, Spain.; Fundación Jiménez Díaz Institute for Medical Research (IIS/FJD), 28040 Madrid, Spain.
Mondaza-Hernandez JL; Institute of Biomedicine of Seville (IBiS, CSIC, US and HUVR), 41013 Sevilla, Spain.
Moura DS; Institute of Biomedicine of Seville (IBiS, CSIC, US and HUVR), 41013 Sevilla, Spain.
Hindi N; Fundacion Jimenez Díaz University Hospital, 28040 Madrid, Spain.; General de Villalba University Hospital, Collado Villalba, 28400 Madrid, Spain.; Fundación Jiménez Díaz Institute for Medical Research (IIS/FJD), 28040 Madrid, Spain.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jun 10; Vol. 13 (12). Date of Electronic Publication: 2021 Jun 10.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Cancer Stem Cells in Soft-Tissue Sarcomas.
Autorzy:
Martínez-Delgado P; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Lacerenza S; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Obrador-Hevia A; Health Research Institute of the Balearic Islands (IdISBa) and Molecular Diagnosis Unit, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.
Lopez-Alvarez M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Mondaza-Hernandez JL; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Blanco-Alcaina E; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Sanchez-Bustos P; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Hindi N; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.; Medical Oncology Department, University Hospital Virgen del Rocio, 41013 Seville, Spain.
Moura DS; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Martin-Broto J; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.; Medical Oncology Department, University Hospital Virgen del Rocio, 41013 Seville, Spain.
Pokaż więcej
Źródło:
Cells [Cells] 2020 Jun 10; Vol. 9 (6). Date of Electronic Publication: 2020 Jun 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplastic Stem Cells/*metabolism
Sarcoma/*physiopathology
Animals ; Humans ; Mice
Czasopismo naukowe
Tytuł:
CUL4A , ERCC5 , and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study.
Autorzy:
Moura DS; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Sanchez-Bustos P; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Fernandez-Serra A; Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.
Lopez-Alvarez M; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Mondaza-Hernandez JL; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Blanco-Alcaina E; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Gavilan-Naranjo A; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Martinez-Delgado P; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Lacerenza S; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Santos-Fernandez P; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.; Medical Oncology Department, University Hospital Virgen del Rocio, 41013 Sevilla, Spain.
Carrasco-Garcia I; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.; Medical Oncology Department, University Hospital Virgen del Rocio, 41013 Sevilla, Spain.
Hidalgo-Rios S; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.
Gutierrez A; Hematology Department, University Hospital Son Espases/IdISBa, 07120 Mallorca, Spain.
Ramos R; Pathology Department, University Hospital Son Espases, 07120 Mallorca, Spain.
Hindi N; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.; Medical Oncology Department, University Hospital Virgen del Rocio, 41013 Sevilla, Spain.
Taron M; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.; Synlab Diagnosticos Globales SAU, 28108 Madrid, Spain.
Lopez-Guerrero JA; Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.; Department of Basic Medical Sciences, School of Medicine, Catholic University of Valencia 'San Vicente Martir', 46001 Valencia, Spain.
Martin-Broto J; Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain.; Medical Oncology Department, University Hospital Virgen del Rocio, 41013 Sevilla, Spain.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Apr 30; Vol. 12 (5). Date of Electronic Publication: 2020 Apr 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies